Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Iradimed (IRMD) Receivables - Net (2016 - 2025)

Iradimed (IRMD) has disclosed Receivables - Net for 13 consecutive years, with $13.7 million as the latest value for Q4 2025.

  • Quarterly Receivables - Net rose 29.47% to $13.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.7 million through Dec 2025, up 29.47% year-over-year, with the annual reading at $13.7 million for FY2025, 29.47% up from the prior year.
  • Receivables - Net for Q4 2025 was $13.7 million at Iradimed, down from $13.9 million in the prior quarter.
  • The five-year high for Receivables - Net was $13.9 million in Q3 2025, with the low at $3.9 million in Q2 2021.
  • Average Receivables - Net over 5 years is $10.1 million, with a median of $11.0 million recorded in 2023.
  • The sharpest move saw Receivables - Net decreased 22.0% in 2021, then skyrocketed 158.43% in 2022.
  • Over 5 years, Receivables - Net stood at $5.1 million in 2021, then surged by 158.43% to $13.3 million in 2022, then dropped by 7.91% to $12.2 million in 2023, then dropped by 13.65% to $10.6 million in 2024, then grew by 29.47% to $13.7 million in 2025.
  • According to Business Quant data, Receivables - Net over the past three periods came in at $13.7 million, $13.9 million, and $10.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.